How to Help Your Patients Save Money on Orgovyx: A Provider's Guide to Savings Programs

Orgovyx (relugolix) is an important advance in oral androgen deprivation therapy for advanced prostate cancer — but its list price of approximately $2,762 per 30-day supply creates real financial barriers for many patients. As a provider, understanding the savings programs available for Orgovyx and proactively enrolling patients in them at the point of prescribing can make the difference between your patients accessing the therapy you've prescribed and abandoning treatment due to cost.

The Financial Landscape for Orgovyx Patients

The cost burden of Orgovyx varies dramatically by payer type:

Commercially insured patients: Best savings options available. Copay Assistance Program can reduce monthly cost to $10/month.

Medicare Part D patients: Cannot use manufacturer copay cards. The 2026 $2,100 Part D out-of-pocket cap helps limit maximum annual exposure. Extra Help and SPAP programs may reduce costs further for low-income patients.

Uninsured or underinsured patients: Patient Assistance Program may provide medication at no cost for those who qualify based on financial need.

Program 1: Orgovyx Copay Assistance Program (Commercial Insurance)

The Orgovyx Copay Assistance Program is the most impactful savings tool for commercially insured patients. Here are the details:

Benefit: Patient pays as little as $10/month for Orgovyx

Annual maximum: $10,000 per calendar year in manufacturer contributions

Frequency restriction: May not be redeemed more than once per 21 days

Exclusions: Not valid for Medicare, Medicaid, Medigap, VA, DoD, TRICARE, or other government-sponsored plans; not valid for cash-paying patients

Enrollment: Call 1-833-ORGOVYX (1-833-674-6899) or visit orgovyxpricing.com. Can be initiated by your practice on the patient's behalf.

Best practice: Train your clinical staff to enroll eligible patients in this program at the time of prescribing, before the prescription is sent to the specialty pharmacy. This prevents surprises at the pharmacy when patients discover the cost.

Program 2: Orgovyx Bridge Program (Coverage Gap Assistance)

The Bridge Program is specifically designed for commercially insured patients who experience a delay or lapse in insurance coverage. Examples include:

Prior authorization is pending or under appeal

Patient is between jobs or changing health plans

Insurance coverage has lapsed for any reason

Benefit: Up to 4 months of Orgovyx at no cost per calendar year. This prevents dangerous treatment interruptions — which are especially critical given that a >7-day interruption requires restarting with a 360 mg loading dose.

Best practice: When initiating Orgovyx for a new patient and the PA is pending, proactively enroll the patient in the Bridge Program so they can start treatment immediately while the coverage question is resolved.

Program 3: Patient Assistance Program (Uninsured/Underinsured)

Sumitomo Pharma America offers a Patient Assistance Program (PAP) for uninsured and underinsured patients who meet financial need criteria. Patients who qualify may receive Orgovyx at no cost or significantly reduced cost.

Your practice can assist patients in applying by:

Contacting the Orgovyx Support Team at 1-833-674-6899 to request PAP application information

Helping the patient complete the income verification documentation required for the application

Also exploring independent charity foundations (PAN Foundation, HealthWell Foundation, CancerCare) which may supplement coverage for oncology medications

Strategies for Medicare Patients

Medicare patients represent a significant portion of your prostate cancer population, and they face more limited savings options. Here's how to maximize affordability for these patients:

Verify Part D formulary coverage before prescribing: Use the Orgovyx hub program's benefits investigation service to confirm the patient's specific Part D plan covers Orgovyx and at what tier.

Explain the 2026 Part D $2,100 out-of-pocket cap: Once patients understand they have a maximum annual exposure, anxiety about the specialty drug cost often decreases. The Medicare Prescription Payment Plan also allows spreading costs across the year.

Screen for Extra Help eligibility: Medicare's Extra Help (Low Income Subsidy) program significantly reduces Part D costs for eligible patients. Refer patients who appear to have limited income to their State Health Insurance Assistance Program (SHIP) for screening.

Check for State Pharmaceutical Assistance Programs (SPAPs): Many states offer additional programs that supplement Medicare Part D for high-cost medications.

Independent Charitable Foundations to Know

When manufacturer programs don't fully cover the patient's need (especially Medicare patients), independent charitable foundations can provide supplemental assistance:

PAN Foundation: Provides grants for Medicare patients with prostate cancer. Visit panfoundation.org.

HealthWell Foundation: Offers financial assistance for patients with prostate cancer on hormonal therapy. Visit healthwellfoundation.org.

CancerCare: Provides financial assistance grants for cancer patients, including for medication costs. Visit cancercare.org.

Building a Practice Workflow for Orgovyx Access

The most effective practices have a systematized approach: a designated staff member who handles specialty pharmacy routing, PA submissions, and patient assistance enrollment for every Orgovyx patient. Integrating the Orgovyx hub program (1-833-674-6899) as a consistent practice resource reduces the burden on your clinical team. For patients who need help locating pharmacies that carry Orgovyx, direct them to medfinder.com/providers — a service that calls pharmacies to find which ones can fill the prescription.